|
Market Closed -
Nyse
02:30:02 21/01/2026 am IST
|
After hours
06:30:00 am
|
|
218.21 USD
|
-0.21%
|
 |
217.50 |
-0.33%
|
|
19/01 |
MediPharm Labs CEO David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
|
MT
| |
19/01 |
Medipharm Labs Corp. Announces CEO Changes, Effective January 23, 2026
|
CI
| |
15/01 |
N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading -- Update
|
DJ
| |
15/01 |
N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading
|
DJ
| |
14/01 |
BD Appoints Shawn Bevec as Senior Vice President of Investor Relations, Effective January 20, 2026
|
CI
| |
12/01 |
Outset Medical, Inc. Announces Board Changes
|
CI
| |
09/01 |
PRESS DIGEST-Wall Street Journal - January 9
|
RE
| |
08/01 |
Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors
|
CI
| |
08/01 |
Jasper Therapeutics, Inc. Announces Executive Changes
|
CI
| |
08/01 |
Jasper Therapeutics, Inc. Announces Chief Executive Officer Changes
|
CI
| |
07/01 |
Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs
|
CI
| |
06/01 |
LB Pharmaceuticals, Inc Announces Appointment of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture
|
CI
| |
05/01 |
Orum Therapeutics Appoints Chad May as Chief Scientific Officer
|
CI
| |
16/12 |
S&P Global Appoints Hubert Joly to the Board of Directors and Member of Audit and Compensation and Leadership Development Committees, Effective January 2, 2026
|
CI
| |
16/12 |
The Hain Celestial Group, Inc. Appoints Alison E. Lewis as President, Effective December 15, 2025
|
CI
| |
10/12 |
Jubilant Foodworks Limited Announces Executive Changes
|
CI
| |
03/12 |
BioCardia, Inc. Announces the Election of Marvin Slosman to Its Board of Directors, Effective December 2, 2025
|
CI
| |
19/11 |
Radiopharm Theranostics Limited Announces Board Changes
|
CI
| |
10/11 |
Celldex Therapeutics, Inc. Announces Executive Changes
|
CI
| |
07/11 |
Relay Therapeutics, Inc. Appoint Board and Committee, Effective November 4, 2025
|
CI
| |
05/11 |
Recursion Pharmaceuticals, Inc. Announces Chief Executive Officer Changes, Effective January 1, 2026
|
CI
| |
05/11 |
Recursion Pharmaceuticals, Inc. Announces Management Changes, Effective January 1, 2026
|
CI
| |
04/11 |
Benitec Biopharma Inc. Appoints Sharon Mates to the Board of Directors, Effective November 2, 2025
|
CI
| |
03/11 |
Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal
|
MT
| |
31/25/31 |
POXEL SA Appoints Yves Decadt as a Member of its Board of Directors
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
